Pembrolizumab (MK-3475) in patients with extensive-stage small cell lung cancer: Preliminary safety and efficacy results from KEYNOTE-028 - Ott, P A; Fernandez, M EE; Hiret, S (J Clin Oncol, 2015)
[ abstract 7502]